These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27904780)

  • 1. Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer.
    Zhang T; Wu Y; Fang Z; Yan Q; Zhang S; Sun R; Khaliq J; Li Y
    Am J Cancer Res; 2016; 6(11):2679-2689. PubMed ID: 27904780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
    Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
    Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting
    Wu F; Li J; Guo N; Wang XH; Liao YQ
    Am J Cancer Res; 2017; 7(3):405-416. PubMed ID: 28401000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of RBMS3 predicts a favorable prognosis in human gallbladder carcinoma.
    Wu Y; Meng D; You Y; Sun R; Yan Q; Bao J; Sun Y; Yun D; Li Y; Sun D
    Oncol Rep; 2020 Jul; 44(1):55-68. PubMed ID: 32627033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.
    Liang YN; Liu Y; Meng Q; Li X; Wang F; Yao G; Wang L; Fu S; Tong D
    Med Oncol; 2015 Feb; 32(2):459. PubMed ID: 25588924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma.
    Sremac M; Paic F; Grubelic Ravic K; Serman L; Pavicic Dujmovic A; Brcic I; Krznaric Z; Nikuseva Martic T
    Oncol Lett; 2021 Dec; 22(6):822. PubMed ID: 34691249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Suppressor Effect of RBMS3 in Breast Cancer.
    Wang C; Wu Y; Liu Y; Pan F; Zeng H; Li X; Yu L
    Technol Cancer Res Treat; 2021; 20():15330338211004921. PubMed ID: 33910421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T Cell Factor 4, beta-catenin and SFRP1 Expression of Wnt Signaling Pathway in Colorectal Carcinoma and the Prognosis].
    Ou Y; Jing G; Liu J; Gao S; Cheng Z; Dong X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Aug; 32(4):854-61. PubMed ID: 26710459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
    Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Secreted Frizzled-Related Protein-1 expression is associated with poor prognosis in intrahepatic cholangiocarcinoma.
    Davaadorj M; Saito Y; Morine Y; Ikemoto T; Imura S; Takasu C; Yamada S; Hiroki T; Yoshikawa M; Shimada M
    Eur J Surg Oncol; 2017 Feb; 43(2):344-350. PubMed ID: 28062160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
    Ren XY; Zhou GQ; Jiang W; Sun Y; Xu YF; Li YQ; Tang XR; Wen X; He QM; Yang XJ; Liu N; Ma J
    Cancer Prev Res (Phila); 2015 Oct; 8(10):968-77. PubMed ID: 26276746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of secreted frizzled-related protein 1 (SFRP1) promoter downregulates Wnt/β-catenin activity in keloids.
    Liu J; Zhu H; Wang H; Li J; Han F; Liu Y; Zhang W; He T; Li N; Zheng Z; Hu D
    J Mol Histol; 2018 Apr; 49(2):185-193. PubMed ID: 29455276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of secreted frizzled-related protein 1 correlate with poor prognosis and promote tumourigenesis in gastric cancer.
    Qu Y; Ray PS; Li J; Cai Q; Bagaria SP; Moran C; Sim MS; Zhang J; Turner RR; Zhu Z; Cui X; Liu B
    Eur J Cancer; 2013 Nov; 49(17):3718-28. PubMed ID: 23927957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression.
    Zhu L; Xi PW; Li XX; Sun X; Zhou WB; Xia TS; Shi L; Hu Y; Ding Q; Wei JF
    J Exp Clin Cancer Res; 2019 Feb; 38(1):105. PubMed ID: 30819235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic value of SFRP1 and β-catenin in patients with glioblastoma.
    Chang L; Lei X; Qin YU; Zeng G; Zhang X; Jin H; Wang C; Wang X; Su J
    Oncol Lett; 2016 Jan; 11(1):69-74. PubMed ID: 26870169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer.
    Zheng L; Sun D; Fan W; Zhang Z; Li Q; Jiang T
    PLoS One; 2015; 10(2):e0118276. PubMed ID: 25719802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation and aberrant expression of Wnt antagonist secreted frizzled-related protein 1 in gastric cancer.
    Zhao CH; Bu XM; Zhang N
    World J Gastroenterol; 2007 Apr; 13(15):2214-7. PubMed ID: 17465504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBMS3, a downstream target of AMPK, Exerts Inhibitory Effects on Invasion and Metastasis of Lung Cancer.
    Lv SL; Zhou X; Li YJ; Luo LY; Huang DQ
    J Cancer; 2023; 14(15):2784-2797. PubMed ID: 37781074
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor suppressor function of RBMS3 overexpression in EOC associated with immune cell infiltration.
    Yin T; Zhang Y; Zhao Y; Zhang X; Han S; Wang Y; Yang B
    Heliyon; 2024 May; 10(9):e30603. PubMed ID: 38726149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of RBMS3 in Breast Cancer Progression.
    Górnicki T; Lambrinow J; Mrozowska M; Romanowicz H; Smolarz B; Piotrowska A; Gomułkiewicz A; Podhorska-Okołów M; Dzięgiel P; Grzegrzółka J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.